Skip to main content

BRIEF-CTD Holdings Reports FDA Authorization To Proceed With Single Patient Ind For Use Of Trappsol Cyclo To Treat Alzheimer's Disease

* CTD HOLDINGS ANNOUNCES FDA AUTHORIZATION TO PROCEED WITH SINGLE PATIENT IND FOR USE OF TRAPPSOL(R) CYCLO(TM) TO TREAT ALZHEIMER'S DISEASE Source text for Eikon: Further company coverage:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.